Anti-psychotic medications are often effective for the positive symptoms of schizophrenia, and allow many patients to lead normal lives. However, many patients suffer from negative symptoms, which include inexpressiveness, deficits in cognitive and emotional skills, and lethargy. To date, the FDA has not approved any drug for the treatment of the negative symptoms of schizophrenia, and from the clinical data available it does not appear as though existing drugs - even new generation drugs - represent a significant improvement in this area. It should be stressed that in addition to the progressive decline in quality of life, the negative symptoms can even hamper psychological and psychiatric treatment, which is often needed in order to complement drug therapy.
As schizophrenia is associated with hypofrontality, repeated activation of prefrontal regions and the deeper reward-related network innervated by the prefrontal cortex, may have long term effects on excitability of these neurons and allow effective treatment of the devastating negative symptoms of schizophrenia. In addition, many schizophrenic patients experience auditory hallucinations.
Brainsway* Deep TMS therapy, or Deep Transcranial Magnetic Stimulation, offers an effective*, safe, non-invasive treatment for Schizophrenia (negative symptoms). Brainsway Deep TMS performs magnetic stimulation of brain structures and networks related to Schizophrenia and brings significant improvement to patients. It is an outpatient procedure which does not require hospitalization or anesthesia, generally well tolerated and entails no systemic side effects*